General Bio

General Bio is a startup based in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

General Bio programs edible microbes to manufacture complex peptide therapeutics at a fraction of the current cost, focusing on oral delivery of drugs such as GLP-1 peptides using genetically engineered microbes as both production and delivery systems.